GlassScriptPhysician profile
Manuel G Rivera Maza
NPI 1144601816
$4,052.12
in general payments reported to CMS, 2019-2025
18 companies · $72.44 in 2025
The $72.44 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $87.65 · 2021: $519 · 2022: $488 · 2023: $2,502 · 2024: $383 · 2025: $72.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,950 · Travel and Lodging: $714 · Grant: $294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,949.92 |
| Travel and Lodging | $713.96 |
| Grant | $294.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,334.49 | 2021-2025 | Versacross Access Solution, Rotapro, Avvigo Guidance System |
| Abbott Laboratories | $677.96 | 2021-2024 | Amplatzer, Mitraclip, Diamondback Coronary |
| Philips North America LLC | $466.75 | 2020-2023 | |
| Siemens Medical Solutions USA, INC. | $269.09 | 2024 | Somatom Force, System Somatom Drive |
| Abiomed | $260.12 | 2023 | Impella |
| Medtronic, INC. | $251.42 | 2021-2023 | Onyx Frontier |
| Biotronik INC. | $212.89 | 2022-2023 | Orsiro Mission |
| Shockwave Medical, INC | $194.50 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $124.34 | 2021 | |
| Inari Medical, INC. | $71.23 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $37.47 | 2023 | Lifevest |
| Irhythm Technologies, INC. | $36.00 | 2024 | Zio Xt Patch, Zio Monitor |
| Edwards Lifesciences Corporation | $32.92 | 2024 | Sapien 3 Ultra Resilia |
| Novartis Pharmaceuticals Corporation | $23.96 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.53 | 2023 | Jardiance |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $21.92 | 2023 | Azur Cx Detachable, Glidewire |
| Pfizer INC. | $13.53 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manuel Rivera Maza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.